Analyze Diet
Frontiers in veterinary science2025; 12; 1507997; doi: 10.3389/fvets.2025.1507997

Azole resistance in Aspergillus isolates from animals or their direct environment (2013-2023): a systematic review.

Abstract: The resistance of species to azoles in human medicine is gaining increasing attention, and the role of animals and agricultural practices in this issue is becoming a significant source of concern. To gain better insights into the occurrence of azole resistance in spp. isolates from animals, a systematic literature review was conducted. Searches were conducted in the PubMed and Scopus databases for articles addressing azole resistance in spp. isolates from both animals and their immediate environments, published between 2013 and 2024. Descriptive clinical cases were analyzed separately from articles providing susceptibility test results. MIC and MIC values, along with the number of non-wild type (NWT) isolates, were either directly extracted from the articles or calculated based on published results of individual isolates or MIC distributions. Ultimately, seventy-three out of 2042 articles were included in the analysis. Articles reporting clinical cases included only horses, dogs, cats, zoo animals, and wildlife, with the majority of cases occurring outside Europe. Generally, successful clinical remission or recovery followed prolonged and continuous fungicide azole treatments, regardless of the azole- spp.-animal category combination. Itraconazole was the most frequently noted treatment in clinical cases involving companion animals (dogs and cats) and horses. The weighted geometric mean of the MIC values for itraconazole was lowest for isolates within the companion animal category. Zoo animals and wildlife were often treated with voriconazole, and the weighted geometric mean of the MIC values for this and other azoles was equal to or slightly lower than those calculated for isolates from other animal categories. NWT isolates were reported in zoo animals and wildlife, horses, companion animals, and poultry for several azoles, occurring both in Europe and beyond, in healthy and sick animals. In conclusion, zoo animals and wildlife, horses, and poultry represent a more significant concern regarding the prevalence of and NWT isolates than other animal categories. Insufficient data prevented conclusions about the situation specifically in Europe, and therefore, more systematic and comparable data are required.
Publication Date: 2025-03-20 PubMed ID: 40182641PubMed Central: PMC11967370DOI: 10.3389/fvets.2025.1507997Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Systematic Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Objective Overview

  • This study systematically reviewed published research on the resistance of Aspergillus species to azole antifungal drugs in animals and their immediate environments from 2013 to 2024.
  • It aimed to understand the occurrence and implications of azole resistance across various animal categories, focusing on clinical cases and susceptibility testing data.

Background and Importance

  • Azoles are a critical class of antifungal drugs used to treat Aspergillus infections, particularly in human medicine.
  • Increasing azole resistance in Aspergillus species raises concerns for treatment efficacy and public health.
  • Animals and agricultural environments may serve as reservoirs or sources for resistant Aspergillus strains, potentially impacting human and animal health.
  • Understanding azole resistance patterns in animal isolates can guide treatment strategies and antimicrobial stewardship.

Methodology

  • A systematic literature search was performed using PubMed and Scopus databases.
  • The search targeted studies published between 2013 and 2024 focusing on azole resistance in Aspergillus isolates collected from animals or their immediate environments.
  • From 2042 identified articles, 73 met inclusion criteria for detailed review.
  • Data extracted included:
    • Clinical case reports involving animal infections with Aspergillus.
    • In vitro antifungal susceptibility test results, specifically minimum inhibitory concentration (MIC) values and non-wild type (NWT) isolate numbers.
  • Data handling involved direct extraction or calculation of MIC and MIC90 values based on reported distributions.

Key Findings

  • Animal Categories Studied: Clinical cases were primarily reported in horses, dogs, cats, zoo animals, and wildlife.
  • Geographic Distribution: Most clinical cases occurred outside Europe, making regional comparisons limited.
  • Treatment Outcomes:
    • Successful remission or recovery was generally achieved with prolonged, continuous azole fungicide therapy.
    • Itraconazole was the most common azole used, especially in dogs, cats, and horses.
  • Susceptibility Data:
    • The weighted geometric mean MICs for itraconazole were lowest in Aspergillus isolates from companion animals, indicating relatively higher susceptibility.
    • Zoo animals and wildlife were often treated with voriconazole, and MIC values for voriconazole and other azoles were similar or slightly lower in these groups compared to others.
  • Resistance Prevalence:
    • NWT isolates, indicating potential resistance, were identified among zoo animals, wildlife, horses, companion animals, and poultry.
    • NWT isolates were detected in both healthy and sick animals and in multiple geographic regions, including Europe.
    • Zoo animals, wildlife, horses, and poultry showed a higher prevalence of NWT isolates compared to other animal categories.

Conclusions and Recommendations

  • Zoo animals, wildlife, horses, and poultry represent important reservoirs for azole-resistant Aspergillus, having implications for animal health and potentially for human exposure.
  • Current data for Europe are insufficient to draw firm conclusions about regional azole resistance patterns in animals.
  • There is a need for more systematic, standardized, and comparable surveillance of azole resistance in animal Aspergillus isolates globally.
  • Improved monitoring could inform clinical treatment decisions and help manage the risk of spread of resistant strains between animals and humans.

Cite This Article

APA
Dieste-Pérez L, Holstege MMC, de Jong JE, Heuvelink AE. (2025). Azole resistance in Aspergillus isolates from animals or their direct environment (2013-2023): a systematic review. Front Vet Sci, 12, 1507997. https://doi.org/10.3389/fvets.2025.1507997

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 12
Pages: 1507997
PII: 1507997

Researcher Affiliations

Dieste-Pérez, Lucía
  • Royal GD, Deventer, Netherlands.
Holstege, Manon M C
  • Royal GD, Deventer, Netherlands.
de Jong, Judith E
  • Royal GD, Deventer, Netherlands.
Heuvelink, Annet E
  • Royal GD, Deventer, Netherlands.

Conflict of Interest Statement

LD-P, MH, JJ and AH were employed by Royal GD. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 79 references
  1. Seyedmousavi S, Guillot J, Arné P, de Hoog GS, Mouton JW, Melchers WJG. and aspergilloses in wild and domestic animals: a global health concern with parallels to human disease.. Med Mycol (2015) 53:765–97.
    doi: 10.1093/mmy/myv067pubmed: 26316211google scholar: lookup
  2. Tell LA. Aspergillosis in mammals and birds: impact on veterinary medicine.. Med Mycol (2005) 43:71–3.
    doi: 10.1080/13693780400020089pubmed: 16110795google scholar: lookup
  3. Davide B, Dionysios N. Invasive aspergillosis and the impact of azole resistance.. Curr Fungal Infect Rep (2023) 17:1–10.
    doi: 10.1007/s12281-023-00459-zpmc: PMC10024029pubmed: 37360857google scholar: lookup
  4. Verweij PE, Arendrup MC, Alastruey-Izquierdo A, Gold JAW, Lockhart SR, Chiller T. Dual use of antifungals in medicine and agriculture: how do we help prevent resistance developing in human pathogens?. Drug Resist (2022) 65:100885.
    doi: 10.1016/j.drup.2022.100885pmc: PMC10693676pubmed: 36283187google scholar: lookup
  5. Talbot JJ, Kidd SE, Martin P, Beatty JA, Barrs VR. Azole resistance in canine and feline isolates of .. Comp Immunol Microbiol Infect Dis (2015) 42:37–41.
    doi: 10.1016/j.cimid.2015.08.002pubmed: 26387063google scholar: lookup
  6. Ziółkowska G, Tokarzewski S, Nowakiewicz A. Drug resistance of strains isolated from flocks of domestic geese in Poland.. Poult Sci (2014) 93:1106–12.
    doi: 10.3382/ps.2013-03702pubmed: 24795302google scholar: lookup
  7. Beernaert LA, Pasmans F, van Waeyenberghe L, Haesebrouck F, Martel A. infections in birds: a review.. Avian Pathol (2010) 39:325–31.
    doi: 10.1080/03079457.2010.506210pubmed: 20954008google scholar: lookup
  8. Taylor AR, Young BD, Levine GJ, Eden K, Corapi W, Rossmeisl JH Jr. Clinical features and magnetic resonance imaging findings in 7 dogs with central nervous system aspergillosis.. J Vet Intern Med (2015) 29:1556–63.
    doi: 10.1111/jvim.13648pmc: PMC4895661pubmed: 26473515google scholar: lookup
  9. Melo UP, Ferreira C, Barreto SWM. Pulmonary aspergillosis in a horse: a case report.. Revista Brasileira de Medicina Veterinaria (2024) 46:e004723.
  10. Thomson P, Toro J, Lara F, Hernández D, Aros K, Valenzuela-Lopez N. First case report of aspergillary rhinopharyngitis in a foal from Chile.. J Equine Vet (2022) 109:103831.
    doi: 10.1016/j.jevs.2021.103831pubmed: 34871753google scholar: lookup
  11. Bunskoek PE, Seyedmousavi S, Gans SJM, van Vierzen PBJ, Melchers WJG, van Elk CE. Successful treatment of azole-resistant invasive Aspergillosis in a bottlenose dolphin with high-dose posaconazole.. Med Mycol Case Rep (2017) 16:16–9.
    doi: 10.1016/j.mmcr.2017.03.005pmc: PMC5382031pubmed: 28409094google scholar: lookup
  12. Kano R, Tsunoi M, Nakaya Y, Nagamine T, Ono K. Antifungal drugs-low-susceptibility in isolated from a captively reared Okinawa rail (Hypotaenidia okinawae).. J Vet Med Sci (2021) 83:28–30.
    doi: 10.1292/jvms.20-0380pmc: PMC7870398pubmed: 33191334google scholar: lookup
  13. Lim SY, Kano R, Ooya K, Kimura S, Yanai T, Hasegawa A. The first isolation of allahabadii from a cormorant with pulmonary aspergillosis.. Med Mycol J (2016) 57:E77–9.
    doi: 10.3314/mmj.16-00016pubmed: 27904055google scholar: lookup
  14. Rose JB, Davies S, Anderson KM, Allan GS, Dennis PM, Malik R. Treatment of mycotic rhinosinusitis in a Bennett’s wallaby () using topical voriconazole suspended in a reverse thermodynamic pluronic gel.. J Zoo Wildl Med (2018) 49:231–6.
    doi: 10.1638/2017-0190R.1pubmed: 29517429google scholar: lookup
  15. Sadar MJ, Guzman DSM, Burton AG, Byrne BA, Wiggans KT, Hollingsworth SR. Mycotic keratitis in a khaki Campbell duck ( domesticus).. J Avian Med Surg (2014) 28:322–9.
    doi: 10.1647/2013-050pubmed: 25843471google scholar: lookup
  16. Kay A, Boland L, Kidd SE, Beatty JA, Talbot JJ, Barrs VR. Complete clinical response to combined antifungal therapy in two cats with invasive fungal rhinosinusitis caused by cryptic species in section Fumigati.. Med Mycol Case Rep (2021) 34:13–7.
    doi: 10.1016/j.mmcr.2021.08.005pmc: PMC8437771pubmed: 34540573google scholar: lookup
  17. Meade E, Savage M, Slattery M, Garvey M. Investigation of alternative therapeutic and biocidal options to combat antifungal-resistant zoonotic fungal pathogens isolated from companion animals.. Infect Dis Rep (2021) 13:348–66.
    doi: 10.3390/IDR13020034pmc: PMC8167567pubmed: 33920450google scholar: lookup
  18. Ralte R, Randhawa SNS, Kumar V, Malik A, Wani MY, Kaur N. Antifungal sensitivity testing of species isolated from recurrent canine skin infection.. Indian J Canine Practice (2022) 14:48–51.
  19. Bartels C, Alvarez-Sanchez A, Ranganathan B, O’Neill TW, Townsend KL. Ventral cervical subcutaneous species fungal granuloma in a cat.. J Feline Med Surg Open Rep (2022) 8.
    doi: 10.1177/20551169221121916pmc: PMC9500275pubmed: 36157251google scholar: lookup
  20. Amorim da Costa FV, Spanamberg A, Araujo R, Werner J, Ferreiro L. Feline sino-orbital fungal infection caused by and scopulariopsis.. Acta Sci Vet (2019) 47:91581.
    doi: 10.22456/1679-9216.91581google scholar: lookup
  21. Kano R, Shibahashi A, Fujino Y, Sakai H, Mori T, Tsujimoto H. Two cases of feline orbital aspergillosis due to udagawae and .. J Vet Med Sci (2013) 75:7–10.
    doi: 10.1292/jvms.12-0119pubmed: 22878535google scholar: lookup
  22. Kano R, Takahashi T, Hayakawa T, Yamaya Y, Hasegawa A, Kamata H. The first case of feline sinonasal aspergillosis due to in Japan.. J Vet Med Sci (2015) 77:1183–5.
    doi: 10.1292/jvms.14-0454pmc: PMC4591165pubmed: 25947561google scholar: lookup
  23. Corrigan VK, Legendre AM, Wheat LJ, Mullis R, Johnson B, Bemis DA. Treatment of disseminated aspergillosis with posaconazole in 10 dogs.. J Vet Intern Med (2016) 30:167–73.
    doi: 10.1111/jvim.13795pmc: PMC4913654pubmed: 26566711google scholar: lookup
  24. Kano R, Sakai M, Hiyama M, Tani K. Isolation of (synonym: Phialosimplex caninus) from a canine iliac lymph node.. Mycopathologia (2019) 184:335–9.
    doi: 10.1007/s11046-018-0312-3pubmed: 30706198google scholar: lookup
  25. Del Magno S, Gruarin M, Foglia A, Cola V, Agnoli C, Galuppi R. Disseminated aspergillosis in a German shepherd mixed breed dog with unusual initial localization to the iliac wing.. Vet Ital (2022) 58:353–60.
    doi: 10.12834/VetIt.2260.15764.2pubmed: 37219837google scholar: lookup
  26. Nevile JC, Hurn SD, Turner AG. Keratomycosis in five dogs.. Vet Ophthalmol (2016) 19:432–8.
    doi: 10.1111/vop.12313pubmed: 26400769google scholar: lookup
  27. Pilkington EJ, de Decker S, Mojarradi A, Rossanese M, Brockman DJ, van den Steen N. Sinonasal mycosis following transfrontal craniotomy in three dogs.. J Am Vet Med Assoc (2022) 260:643–9.
    doi: 10.2460/javma.21.03.0115pubmed: 34986118google scholar: lookup
  28. Smith CG, Woolford L, Talbot JJ, Lee KC, Crocker P. Canine rhinitis caused by an uncommonly-diagnosed fungus, Scedosporium apiospermum.. Med Mycol Case Rep (2018) 22:38–41.
    doi: 10.1016/j.mmcr.2018.08.004pmc: PMC6104628pubmed: 30140605google scholar: lookup
  29. Yang W, Jones BR, Rossi G, Stephens N, Arthur I, Merritt A. First case of a dog infected with (Phialosimplex) caninus in Australasia.. N Z Vet J (2020) 68:231–7.
    doi: 10.1080/00480169.2019.1706659pubmed: 31852374google scholar: lookup
  30. Ygreda G, Andrade R, Jara LM. Canine otitis externa by pathogenic : case report.. Revista de Investigaciones Veterinarias del Peru (2021) 32:e20934.
  31. Álvarez-Pérez S, García ME, Martínez-Nevado E, Blanco JL. Presence of with the TR34/L98H Cyp51A mutation and other azole-resistant aspergilli in the air of a zoological park. Res Vet Sci (2023) 164:104993.
    doi: 10.1016/j.rvsc.2023.104993pubmed: 37657393google scholar: lookup
  32. Barber AE, Scheufen S, Walther G, Kurzai O, Schmidt V. Low rate of azole resistance in cases of avian aspergillosis in Germany. Med Mycol (2020) 58:1187–90.
    doi: 10.1093/mmy/myaa045pubmed: 32497229google scholar: lookup
  33. Bralet T, Risco-Castillo V, Valsecchi I, Laidebeure S, Sailler A, Lécu A. Aspergillosis in a colony of Humboldt penguins () in a french zoological park: evaluation of environmental exposure. Vet Res Commun (2024) 48:437–48.
    doi: 10.1007/s11259-023-10220-zpubmed: 37819485google scholar: lookup
  34. Melo AM, Poester VR, Canabarro PL, Sampaio DA, Stevens DA, Veríssimo C. Molecular epidemiology of aspergillosis in Magellanic penguins and susceptibility patterns of clinical isolates. Med Mycol (2021) 59:1076–84.
    doi: 10.1093/mmy/myab040pubmed: 34320182google scholar: lookup
  35. Sabino R, Burco J, Valente J, Veríssimo C, Clemons KV, Stevens DA. Molecular identification of clinical and environmental avian isolates. Arch Microbiol (2019) 201:253–7.
    doi: 10.1007/s00203-019-01618-ypubmed: 30627760google scholar: lookup
  36. Viegas C, Monteiro A, Ribeiro E, Caetano LA, Carolino E, Assunção R. Organic dust exposure in veterinary clinics: a case study of a small-animal practice in Portugal. Arh Hig Rada Toksikol (2018) 69:309–16.
    doi: 10.2478/aiht-2018-69-3171pubmed: 30864379google scholar: lookup
  37. Bendary MM, Abd el-Hamid MI, Abousaty AI, Elmanakhly AR, Alshareef WA, Mosbah RA. Therapeutics switching of Rafoxanide: a new approach to fighting drug-resistant bacteria and fungi. Microbiol Spectrum (2023) 11:e0267922.
    doi: 10.1128/spectrum.02679-22pmc: PMC10433953pubmed: 37458598google scholar: lookup
  38. Brito Devoto T, Toscanini MA, Hermida Alava K, Etchecopaz AN, Pola SJ, Martorell MM. Exploring fungal diversity in Antarctic wildlife: isolation and molecular identification of culturable fungi from penguins and pinnipeds. N Z Vet J (2022) 70:263–72.
    doi: 10.1080/00480169.2022.2087784pubmed: 35673970google scholar: lookup
  39. Cateau E, Leclerc A, Cartier N, Valsecchi I, Bailly É, le Senechal R. Aspergillosis in a colony of Humboldt penguins () under managed care: a clinical and environmental investigation in a French zoological park. Med Mycol (2022) 60:myac046.
    doi: 10.1093/mmy/myac046pubmed: 35713494google scholar: lookup
  40. Cruciani D, Crotti S, Maresca C, Pecorelli I, Verdini E, Rodolfi M. Preliminary investigation about spp. spread in Umbrian avian farms. J Fungi (2022) 8:1213.
    doi: 10.3390/jof8111213pmc: PMC9698509pubmed: 36422034google scholar: lookup
  41. Cullen M, Jacob ME, Cornish V, VanderSchel IQ, Cotter HVT, Cubeta MA. Multi-locus DNA sequence analysis, antifungal agent susceptibility, and fungal keratitis outcome in horses from southeastern United States. PLoS One (2019) 14:e0214214.
  42. Debergh H, Becker P, Vercammen F, Lagrou K, Haesendonck R, Saegerman C. Pulmonary aspergillosis in Humboldt penguins—susceptibility patterns and molecular epidemiology of clinical and environmental isolates from a Belgian zoo, 2017–2022. Antibiotics (2023) 12:584.
  43. Lofgren LA, Lorch JM, Cramer RA, Blehert DS, Berlowski-Zier BM, Winzeler ME. ‘Avian-associated displays broad phylogenetic distribution, no evidence for host specificity, and multiple genotypes within epizootic events’, G3: genes, genomes. Genetics (2022) 12:75.
    doi: 10.1093/g3journal/jkac075pmc: PMC9073692pubmed: 35377435google scholar: lookup
  44. Martinez PS, Whitley RD, Plummer CE, Richardson RL, Hamor RE, Wellehan JFX. antifungal susceptibility of species and cultured from eleven horses with fungal keratitis. Vet Ophthalmol (2022) 25:376–84.
    doi: 10.1111/vop.12995pubmed: 35684950google scholar: lookup
  45. Mustikka MP, Grönthal TSC, Pietilä EM. Equine infectious keratitis in Finland: associated microbial isolates and susceptibility profiles. Vet Ophthalmol (2020) 23:148–59.
    doi: 10.1111/vop.12701pmc: PMC7004187pubmed: 31364808google scholar: lookup
  46. Mutlu SF, Silici S, Koc AN, Sagiroglu P, Dinc B. Does dry or fresh bee bread contain clinically significant, and antimicrobial agents resistant microorganisms. J Agric Sci (2023) 29:534–45.
    doi: 10.2022/Acceptedgoogle scholar: lookup
  47. Nawrot U, Wieliczko A, Włodarczyk K, Kurzyk E, Brillowska-Dąbrowska A. Low frequency of itraconazole resistance found among originating from poultry farms in Southwest Poland. J Mycologie Medicale (2019) 29:24–7.
    doi: 10.1016/j.mycmed.2018.12.005pubmed: 30616967google scholar: lookup
  48. Ohno Y, Akune Y, Inoshima Y, Kano R. First isolation of voriconazole-resistant , C. 4 tropicalis, and from the blowholes of 5 bottlenose dolphins (). J Vet Med Sci (2019).
    doi: 10.1292/jvms.18-0749pmc: PMC6895615pubmed: 31611481google scholar: lookup
  49. Roberts D, Cotter HVT, Cubeta M, Gilger BC. susceptibility of and associated with equine keratitis to new antifungal drugs. Vet Ophthalmol (2020) 23:918–22.
    doi: 10.1111/vop.12774pubmed: 32418311google scholar: lookup
  50. Sarrafha MR, Hashemi SJ, Rezaei S, Bayat M. ‘ evaluation of the effects of fluconazole and nano-fluconazole on and isolates’. Jundishapur J Microbiol (2018) 11:57875.
    doi: 10.5812/jjm.57875google scholar: lookup
  51. Spanamberg A, Ravazzolo AP, Denardi LB, Hartz SA, Santurio JM, Driemeier D. Antifungal susceptibility profile of isolates from avian lungs. Pesqui Vet Bras (2020) 40:102–6.
  52. Tartor YH, Hassan FAM. Assessment of carvacrol for control of avian aspergillosis in intratracheally challenged chickens in comparison to voriconazole with a reference on economic impact. J Appl Microbiol (2017) 123:1088–99.
    doi: 10.1111/jam.13557pubmed: 28795522google scholar: lookup
  53. Uchida-Fujii E, Kuroda T, Niwa H, Kinoshita Y, Kano R, Tamura T. Bacterial and fungal isolates from 107 cases of ulcerative keratitis in Japanese thoroughbred racehorses (2017–2021). J Equine Vet (2024) 133:104990.
    doi: 10.1016/j.jevs.2023.104990pubmed: 38159581google scholar: lookup
  54. Valdes ID, van den Berg J, Haagsman A, Escobar N, Meis JF, Hagen F. Comparative genotyping and phenotyping of isolates from humans, dogs and the environment. BMC Microbiol (2018) 18:118.
    doi: 10.1186/s12866-018-1244-2pmc: PMC6142626pubmed: 30223790google scholar: lookup
  55. Vedova RD, Hevia A, Vivot W, Fernández J, Córdoba SB, Reynaldi FJ. Aspergillosis in domestic and wild birds from Argentina. Braz J Vet Res Anim Sci (2019) 56:e152460.
  56. Voelter-Ratson K, Monod M, Unger L, Spiess BM, Pot SA. Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland. Vet Ophthalmol (2014) 17:31–6.
    doi: 10.1111/vop.12088pubmed: 23910390google scholar: lookup
  57. Wang DY, Gricourt M, Arné P, Thierry S, Seguin D, Chermette R. Mutations in the Cyp51A gene and susceptibility to itraconazole in isolated from avian farms in France and China. Poult Sci (2014) 93:12–5.
    doi: 10.3382/ps.2013-03541pubmed: 24570417google scholar: lookup
  58. Ayandiran TA, Dauhnsi SO. Microbial evaluation and occurrence of antidrug multi-resistant organisms among the indigenous Clarias species in river Oluwa, Nigeria. J King Saud Univ Sci (2017) 29:96–105.
  59. Barrs VR, van Doorn TM, Houbraken J, Kidd SE, Martin P, Pinheiro MD. sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs. PlosOne (2013) 8:e64871.
  60. Iatta R, Nuccio F, Immediato D, Mosca A, de Carlo C, Miragliotta G. Species distribution and azole susceptibility of section Nigri isolates from clinical and environmental settings. J Clin Microbiol (2016) 54:2365–72.
    doi: 10.1128/jcm.01075-16pmc: PMC5005483pubmed: 27413191google scholar: lookup
  61. Mo PM, Picard J, Gummow B. The conjunctival fungal microfora of horses in a North Queensland tropical environment and their susceptibilities to antifungal agents.. Vet Res Commun (2023) 47:1641–51.
    doi: 10.1007/s11259-023-10119-9pmc: PMC10485094pubmed: 37022654google scholar: lookup
  62. Rashid MH, Qureshi ZI, Ali S, Khan HH, Masood A, Nawaz H. Prevalence of mycotic endometritis in buffaloes and mares maintained under different managemental conditions in district Faisalabad.. Pakistan Vet J (2021).
    doi: 10.29261/pakvetj/2021.034google scholar: lookup
  63. Reed K, Macgregor SK, Stidworthy MF, Denk D, Guthrie A. The isolation and antimicrobial sensitivity of from frozen respiratory tissues of penguins from zoological collections in the United Kingdom 2007-2018.. J Zoo Wildl Med (2020) 51:591–7.
    doi: 10.1638/2019-0160pubmed: 33480534google scholar: lookup
  64. Sabino R, Carolino E, Veríssimo C, Martinez M, Clemons KV, Stevens DA. Antifungal susceptibility of 175 isolates from various clinical and environmental sources.. Med Mycol (2016) 54:740–56.
    doi: 10.1093/mmy/myw024pubmed: 27143632google scholar: lookup
  65. White JK, Nielsen JL, Poulsen JS, Madsen AM. Antifungal resistance in isolates of from a pig farm.. Atmos (2021) 12:826.
    doi: 10.3390/atmos1207082google scholar: lookup
  66. Afshan Naz S., Shafique M.. Isolation of potentially pathogenic fungi from selected pigeons’ feeding sites in Karachi: a new dimension to health hazard. J Pak Med Assoc .
    pubmed: 28585590
  67. Aneke CI, Ugochukwu ICI, Okafor J, Chah KF. Prevalence and antifungal susceptibility of mycotic agents isolated from skin lesions of horses in Enugu state, Nigeria.. Comp Clin Pathol (2018) 27:589–95.
    doi: 10.1007/s00580-017-2632-ygoogle scholar: lookup
  68. Colombo SA, de Mello DMD, Morais BRM, Salvato LA, Dorella FA, Tavares GC. Characterization of the fungal microbiota of in the nostrils and rectum of Amazon manatees () from a rehabilitation program in Brazil.. J Zoo Wildl Med (2024) 55:125–35.
    doi: 10.1638/2022-0069pubmed: 38453495google scholar: lookup
  69. El-Hamaky AMA, Hassan AA, Wahba AKA, El Mosalamy MMEA. Influence of copper and zinc nanoparticles on genotyping characterizations of multi-drug resistance genes for some calf pathogens.. Int J Vet Sci (2023) 12:309–17.
  70. Fahmy HA, Mahrous E, Sayed-Elahl RM. Detection of multidrug resistant strains in some pathogenic bacteria and fungi caused otitis in pet animals.. Int J Vet Sci (2020) 9:453–7.
    doi: 10.37422/ijvs/20.059google scholar: lookup
  71. Hampson ECGM, Gibson JS, Barot M, Shapter FM, Greer RM. Identification of bacteria and fungi sampled from the conjunctival surface of normal horses in south-East Queensland, Australia.. Vet Ophthalmol (2019) 22:265–75.
    doi: 10.1111/vop.12587pubmed: 29963751google scholar: lookup
  72. Mgbeahuruike AC, Agoha A, ICI U, Ezema W, Onoja RI. Prevalence of pulmonary mycotic lesions and antifungal susceptibility pattern of fungi isolated from nigerian trade cattle.. Int J Vet Sci (2021) 10:294–300.
  73. Mohammed AN, Abdel-Latef GK. Environmental monitoring of zoonotic fungal infection in broiler chickens: novel approach to control using Nano-fungicide composite.. Trop Anim Sci J (2021) 44:336–46.
  74. Sadiek Y, El TYA, Amen O. Role of essential oil for control of avian aspergillosis in experimentally infected chickens.. Assiut Vet Med J (2019).
    doi: 10.21608/avmj.2019.169204google scholar: lookup
  75. El Tawab AAA, El Hofy FI, Moustafa EM, Halawa MR. Insight into isolation, identification and antimicrobial sensitivity of some moulds isolated from fresh water fishes.. Adv Anim Vet Sci (2020) 8:174–82.
  76. Das S, Christu SD, Silvanose C, Binoy A, Azmanis P, Di Somma A. Emerging antifungal resistance in Falco species: a novel model for human medicine.. Biol Med (2023) 15:586.
  77. Moore CB, Sayers N, Mosquera J, Slaven J, Denning DW. Antifungal drug resistance in .. J Infect (2000) 41:203–20.
    doi: 10.1053/jinf.2000.0747pubmed: 11120607google scholar: lookup
  78. Rhodes J, Abdolrasouli A, Dunne K, Sewell TR, Zhang Y, Ballard E. Population genomics confirms acquisition of drug-resistant infection by humans from the environment.. Nat Microbiol (2022) 7:663–74.
    doi: 10.1038/s41564-022-01091-2pmc: PMC9064804pubmed: 35469019google scholar: lookup
  79. Rivelli Zea SM, Toyotome T. Azole-resistant as an emerging worldwide pathogen.. Microbiol Immunol (2022) 66:135–44.
    doi: 10.1111/1348-0421.12957pubmed: 34870333google scholar: lookup

Citations

This article has been cited 1 times.
  1. Shiroma Buri MC, Castro-Ríos K, Ramalho da Cruz AD, Claudio TM, Ceresini PC. A One Health Perspective on Aspergillus fumigatus in Brazilian Dry Foods: High Genetic Diversity and Azole Susceptibility.. J Fungi (Basel) 2026 Jan 16;12(1).
    doi: 10.3390/jof12010072pubmed: 41590484google scholar: lookup